Cargando…

Development and application of a diagnostic and severity scale to grade post-operative pediatric cerebellar mutism syndrome

The post-operative pediatric cerebellar mutism syndrome (CMS) affects about one-third of children and adolescents following surgical removal of a posterior fossa tumor (PFT). According to the Posterior Fossa Society consensus working definition, CMS is characterized by delayed-onset mutism/reduced s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricci, Federica S., D’Alessandro, Rossella, Somà, Alessandra, Salvalaggio, Anna, Rossi, Francesca, Rampone, Sara, Gamberini, Giorgia, Davico, Chiara, Peretta, Paola, Cacciacarne, Mario, Gaglini, Pierpaolo, Pacca, Paolo, Pilloni, Giulia, Ragazzi, Paola, Bertin, Daniele, Vallero, Stefano G., Fagioli, Franca, Vitiello, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897365/
https://www.ncbi.nlm.nih.gov/pubmed/34651204
http://dx.doi.org/10.1007/s00431-021-04290-x
Descripción
Sumario:The post-operative pediatric cerebellar mutism syndrome (CMS) affects about one-third of children and adolescents following surgical removal of a posterior fossa tumor (PFT). According to the Posterior Fossa Society consensus working definition, CMS is characterized by delayed-onset mutism/reduced speech and emotional lability after cerebellar or 4th ventricle tumor surgery in children, and is frequently accompanied by additional features such as hypotonia and oropharyngeal dysfunction/dysphagia. The main objective of this work was to develop a diagnostic scale to grade CMS duration and severity. Thirty consecutively referred subjects, aged 1–17 years (median 8 years, IQR 3–10), were evaluated with the proposed Post-Operative Pediatric CMS Survey after surgical resection of a PFT and, in case of CMS, for 30 days after the onset (T(0)) or until symptom remission. At day 30 (T(1)), CMS was classified into mild, moderate, or severe according to the proposed scale. CMS occurred in 13 patients (43%, 95% C.I.: 25.5–62.6%), with mild severity in 4 cases (31%), moderate in 4 (31%), and severe in 5 (38%). At T(1), longer symptom persistence was associated with greater severity (p = 0.01). Greater severity at T(0) predicted greater severity at T(1) (p = 0.0001). Children with a midline tumor location and those aged under 5 years at diagnosis were at higher risk of CMS (p = 0.025 and p = 0.008, respectively). In conclusion, the proposed scale is a simple and applicable tool for estimating the severity of CMS at its onset, monitoring its course over time, and providing an early prognostic stratification to guide treatment decisions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00431-021-04290-x.